NO20072615L - Biomarkor for hjertesvikt - Google Patents

Biomarkor for hjertesvikt

Info

Publication number
NO20072615L
NO20072615L NO20072615A NO20072615A NO20072615L NO 20072615 L NO20072615 L NO 20072615L NO 20072615 A NO20072615 A NO 20072615A NO 20072615 A NO20072615 A NO 20072615A NO 20072615 L NO20072615 L NO 20072615L
Authority
NO
Norway
Prior art keywords
heart failure
biomarker
patients
ark1
lymphocytes
Prior art date
Application number
NO20072615A
Other languages
English (en)
Norwegian (no)
Inventor
Walter J Koch
Guido Iaccarino
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Publication of NO20072615L publication Critical patent/NO20072615L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20072615A 2004-11-08 2007-05-22 Biomarkor for hjertesvikt NO20072615L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62571904P 2004-11-08 2004-11-08
PCT/US2005/040231 WO2006052857A2 (en) 2004-11-08 2005-11-04 Biomarker for heart failure

Publications (1)

Publication Number Publication Date
NO20072615L true NO20072615L (no) 2007-08-06

Family

ID=36337092

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072615A NO20072615L (no) 2004-11-08 2007-05-22 Biomarkor for hjertesvikt

Country Status (13)

Country Link
US (1) US20090053696A1 (pt)
EP (1) EP1810027A4 (pt)
JP (1) JP2008519283A (pt)
KR (1) KR20070101241A (pt)
CN (1) CN101084439A (pt)
AU (1) AU2005304819A1 (pt)
BR (1) BRPI0515727A (pt)
CA (1) CA2586922A1 (pt)
IL (1) IL183036A0 (pt)
MX (1) MX2007005435A (pt)
NO (1) NO20072615L (pt)
WO (1) WO2006052857A2 (pt)
ZA (1) ZA200703666B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4778807B2 (ja) * 2006-02-17 2011-09-21 株式会社リコー 画像形成装置
EP2646572B1 (en) * 2010-12-01 2017-02-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Diagnostic and treatment of chronic heart failure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2228970A1 (en) * 1995-08-18 1997-02-27 Donald W. Landry Detection of organic compounds through regulation of antibody-catalyzed reactions
CA2551882A1 (en) * 2004-01-19 2005-08-11 Martek Biosciences Corporation Reelin deficiency or dysfunction and methods related thereto

Also Published As

Publication number Publication date
CN101084439A (zh) 2007-12-05
IL183036A0 (en) 2007-09-20
US20090053696A1 (en) 2009-02-26
KR20070101241A (ko) 2007-10-16
MX2007005435A (es) 2007-07-24
EP1810027A4 (en) 2008-05-28
ZA200703666B (en) 2008-10-29
AU2005304819A1 (en) 2006-05-18
JP2008519283A (ja) 2008-06-05
WO2006052857A2 (en) 2006-05-18
EP1810027A2 (en) 2007-07-25
WO2006052857A3 (en) 2006-10-19
BRPI0515727A (pt) 2008-08-05
CA2586922A1 (en) 2006-05-18

Similar Documents

Publication Publication Date Title
NO20081198L (no) Fremgangsmate for a predikere eller monitorere en pasients respons til et medikament rettet mot en ErbB-reseptor
NO20071831L (no) Anvendelse av unormal hendelsesdeteksjonsteknologi for hydrocrackingenheter
DK1991697T3 (da) DNA-konformation (LOOP-strukturer) ved normal og anormal genekspression
WO2008089994A8 (en) Use of igfbp-7 in the assessment of heart failure
WO2004096985A3 (en) Methods for assessing biologic diversity
NO20093384L (no) Sykdomsmarkorer
BRPI0715126B8 (pt) métodos para avaliação do risco de intervenções cardíacas e usos à base de gdf-15
WO2007001342A3 (en) Exhaled breath condensate collection and assay system and method
WO2008084331A3 (en) Biomarkers for renal disorders
WO2005076887A3 (en) Methods and systems for sampling, screening, and diagnosis
NO20073680L (no) Fremgangsmate for a analysere data som har felles og saerskilte egenskaper
WO2010081981A3 (fr) Procédé de détermination de la teneur d'une pluralité de composés contenus dans un fluide de forage.
DK1974210T3 (da) Fremgangsmåde til diagnosticering af polycystisk nyresygdom
DK1758555T4 (da) Triterpenholdig oleogendanner, triterpenholdig oleogel og fremgangsmåde til fremstilling af en triterpenholdig oleogel
WO2008003066A3 (en) Apparatus, compositions, and methods for assessment of chronic obstructive pulmonary disease progression among rapid and slow decline conditions
EA200801297A1 (ru) Способ снижения уровня постпрандиальной глюкозы
WO2005048818A3 (en) Methods of diagnosing renal disease
IL166194A (en) Plasma urotensin in human heart failure
DE602005014778D1 (de) Timp-2 als ziel/marker des versagens von beta-zellen
NZ594843A (en) Method or system using biomarkers for the monitoring of a treatment
EP1860430A4 (en) METHOD FOR DIAGNOSIS OF UNUSUAL CONDITIONS OF A GAS CONCENTRATION DETECTION UNIT AND DEVICE FOR DIAGNOSIS OF UNUSUAL CONDITIONS OF A GAS CONCENTRATION DETECTION UNIT
WO2010144553A3 (en) Methods for diagnosing blood vessel reocclusion
WO2007079301A3 (en) Method of diagnosing a body weight condition or predisposition in an animal
NO20072615L (no) Biomarkor for hjertesvikt
WO2005034737A3 (en) Methods for diagnosing and treating endoplasmic reticulum (er) stress diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application